Literature DB >> 25312216

P2X receptors and diabetes.

Carmen Fotino, Andrea Vergani, Paolo Fiorina, Antonello Pileggi1.   

Abstract

Diabetes is a metabolic disorder characterized by elevation of glucose levels in the blood that develops in humans as a result of genetic predisposition and environmental factors. Unbalanced glycemic control has been associated with the development of progressive and debilitating complications that dramatically affect the quality of life and life expectancy of people with diabetes. The purinergic system represents a widely diffused signaling pathway in mammalian cells of different tissues where it plays critical roles in both physiological and pathological conditions. Herein we review the increasing evidence supporting that the purinergic system plays an important role in the multiple facets of diabetes, including its physiopathology and complications. We also discuss the potential relevance of the purinergic pathway for diagnosis and treatment of diabetes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25312216     DOI: 10.2174/0929867321666141012173520

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

1.  Small Molecule Differentiate PDX1-Expressing Cells Derived from Human Endometrial Stem Cells on PAN Electrospun Nanofibrous Scaffold: Applications for the Treatment of Diabetes in Rat.

Authors:  Saad Gooraninejad; Elham Hoveizi; Kiavash Hushmandi; Sina Gooraninejad; Seyed Reza Fatemi Tabatabaei
Journal:  Mol Neurobiol       Date:  2020-07-07       Impact factor: 5.590

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

3.  2',3'-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents.

Authors:  Diego Dal Ben; Anna Marchenkova; Ajiroghene Thomas; Catia Lambertucci; Andrea Spinaci; Gabriella Marucci; Andrea Nistri; Rosaria Volpini
Journal:  Purinergic Signal       Date:  2016-10-18       Impact factor: 3.765

Review 4.  The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy.

Authors:  Mariana Alves; Edward Beamer; Tobias Engel
Journal:  Front Pharmacol       Date:  2018-03-07       Impact factor: 5.810

5.  P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response.

Authors:  Theodomir Dusabimana; So Ra Kim; Eun Jung Park; Jihyun Je; Kyuho Jeong; Seung Pil Yun; Hye Jung Kim; Hwajin Kim; Sang Won Park
Journal:  Mol Metab       Date:  2020-09-25       Impact factor: 7.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.